Acamprosate Inhibits the Binding and Neurotoxic Effects of Trans-ACPD, Suggesting a Novel Site of Action at Metabotropic Glutamate Receptors
- 1 December 2002
- journal article
- research article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 26 (12) , 1779-1793
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant miceNature Neuroscience, 2001
- Selective mGluR5 antagonists MPEP and SIB‐1893 decrease NMDA or glutamate‐mediated neuronal toxicity through actions that reflect NMDA receptor antagonismBritish Journal of Pharmacology, 2000
- Clinical Pharmacokinetics of AcamprosateClinical Pharmacokinetics, 1998
- Analysis of glutamate receptors in primary cultured neurons from fetal rat forebrainNeurochemical Research, 1995
- NMDA Receptors in Rat Cerebellum and Forebrain: Subtle Differences in Pharmacology and ModulationJournal of Neurochemistry, 1995
- Distribution and Ontogeny of 1S,3R‐1‐Aminocyclopentane‐1,3‐Dicarboxylic Acid‐Sensitive and Quisqualate‐Insensitive [3H]Glutamate Binding Sites in the Rat BrainJournal of Neurochemistry, 1994
- Polyamines modulate the function of transfected glutamate receptor mGluR1aNeuroReport, 1993
- Characterization of metabotropic glutamate receptors coupled to a pertussis toxin sensitive G-protein in bovine brain coated vesiclesFEBS Letters, 1993
- Comparison of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD)- and 1R,3S-ACPD-stimulated brain phosphoinositide hydrolysisEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Cellular and connective organization of slice cultures of the rat hippocampus and fascia dentataJournal of Comparative Neurology, 1984